Trending...
- Radarsign™ Awarded Sourcewell Contract Expanding Access to Traffic Safety Solutions - 147
- California: Governor Newsom launches first new conservancy in 15 years to accelerate progress at the Salton Sea - 123
- Art In Stone, a 40-Year Bay Area Monument Leader, Launches Newly Renovated Website
SAN DIEGO - Californer -- Calmodulin Dependent Protein Kinase II 281-309
Catalog Number: B2016561 (100 ug)
Calmodulin Dependent Protein Kinase II 281-309 is a high quality protein kinase that is activated by the binding of calcium-calmodulin. The sequence 281-309 likely refers to a specific region within the CaMKII protein. This region may be important for the regulation of the kinase activity or for its interaction with other proteins. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Calmodulin Dependent Protein Kinase II 281-309
Catalog number: B2016561
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: N/A
More on The Californer
Supplied as: Powder
Applications: a molecular tool for various biochemical applications
Storage: −20°C
Keywords: Calmodulin Dependent Protein Kinase II 281-309
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Colbran RJ, Smith MK, Schworer CM, Fong YL, Soderling TR. Regulatory domain of calcium/calmodulin-dependent protein kinase II. Mechanism of inhibition and regulation by phosphorylation J Biol Chem. 1989 Mar 25;264(9):4800-4.
2: Ishida A, Fujisawa H. Stabilization of calmodulin-dependent protein kinase II through the autoinhibitory domain J Biol Chem. 1995 Feb 3;270(5):2163-70.
https://moleculardepot.com/product/calmodulin-dependent-protein-kinase-ii-281-309/
Catalog Number: B2016561 (100 ug)
Calmodulin Dependent Protein Kinase II 281-309 is a high quality protein kinase that is activated by the binding of calcium-calmodulin. The sequence 281-309 likely refers to a specific region within the CaMKII protein. This region may be important for the regulation of the kinase activity or for its interaction with other proteins. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Calmodulin Dependent Protein Kinase II 281-309
Catalog number: B2016561
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: N/A
More on The Californer
- Stellar Winery Lineup to Pour at 38th Annual Ojai Wine Festival
- New Book: The Battle for Truth and Shadows - Guardians of Light - Epic Fantasy Unveils a War Between Light and Deception
- Clash of Prompts: The World's First AI Prompt Battle Royale
- California: Governor Newsom announces the latest digital technology at the DMV to fight identity fraud and reduce wait times
- $7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
Supplied as: Powder
Applications: a molecular tool for various biochemical applications
Storage: −20°C
Keywords: Calmodulin Dependent Protein Kinase II 281-309
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Colbran RJ, Smith MK, Schworer CM, Fong YL, Soderling TR. Regulatory domain of calcium/calmodulin-dependent protein kinase II. Mechanism of inhibition and regulation by phosphorylation J Biol Chem. 1989 Mar 25;264(9):4800-4.
2: Ishida A, Fujisawa H. Stabilization of calmodulin-dependent protein kinase II through the autoinhibitory domain J Biol Chem. 1995 Feb 3;270(5):2163-70.
https://moleculardepot.com/product/calmodulin-dependent-protein-kinase-ii-281-309/
Source: Molecular Depot
Filed Under: Biotech
0 Comments
Latest on The Californer
- Central Florida Luxury Real Estate Firm DANHOLM COLLECTION Partners with Luxury Presence to Expand Global Buyer Reach
- Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps
- Matter Studio Gallery Presented "Evolving Matter," a Pop-Up Exhibition Examining Material Transformation and Contemporary Form
- Gourmet Genie Is Redefining Street Food in Los Angeles — One Bite at a Time
- Chef Raphael Gamon announces Cooking with Traditional Medicine:
- Corporate West Computer Systems Launches "Safe Start" Cyber Security Program for SMBs
- Governor Newsom calls on Trump administration to remove roadblocks to California's expansion of essential health benefits, including IVF
- Let's go fishing! Salmon fishing is back in California after more than 3-year closure
- City Accepting Applications for Fourth Cohort of Long Beach Public Service Corps
- Strawberries Take Center Stage At 40th Annual California Strawberry Festival, May 16 and 17
- BevWire Unveils "North America NA Alt-Beverage Opportunities 2026" Market Intelligence Report
- InterMountain Management Announces the Re-opening of Holiday Inn Express & Suites Alexandria
- Maui After the Storm: Travel That Gives Back
- California: As weekend one of Coachella wraps, Governor Newsom highlights economic power of Indio's world-renowned music festivals
- CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH
- Contracting Resources Group Named to the 2026 Inc. Regionals: Mid-Atlantic List
- Connect names Marshall Fritz as Director of Tech & Defense to drive innovation and capital pathways
- Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports
- Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
- Christopher Hunt Verified 8 Figure Trader with 15.5M 2024 Profits